Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 2/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 13/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19873653 | 1.00 | LPAR1 (0.40) | LPAR1JAK2CHRM3ENPP2CHRM2 | |
| SCHEMBL19873646 | 0.94 | LPAR1 (0.40) | LPAR1JAK2CHRM3ENPP2CHRM2 | |
| SCHEMBL19873648 | 0.94 | LPAR1 (0.40) | LPAR1JAK2CHRM3ENPP2CHRM2 | |
| SCHEMBL19873632 | 0.92 | LPAR1 (0.44) | LPAR1CHRM3ENPP2CHRM2CHRM1 | |
| SCHEMBL19873633 | 0.92 | LPAR1 (0.44) | LPAR1CHRM3ENPP2CHRM2CHRM1 | |
| SCHEMBL19873586 | 0.91 | LPAR1 (0.34) | LPAR1JAK2CHRM3CHRM2CHRM1 | |
| SCHEMBL19873588 | 0.91 | LPAR1 (0.34) | LPAR1JAK2CHRM3CHRM2CHRM1 | |
| SCHEMBL19873661 | 0.90 | LPAR1 (0.39) | LPAR1JAK2CHRM3CHRM2CHRM1 | |
| SCHEMBL19873664 | 0.90 | LPAR1 (0.39) | LPAR1JAK2CHRM3CHRM2CHRM1 | |
| SCHEMBL19873580 | 0.88 | ENPP2 (0.33) | LPAR1JAK2CHRM3ENPP2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3360869-B1 | HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND USEFUL FOR THE TREATMENT OF DISEASES CAUSED BY LPA. | UBE INDUSTRIES (JP) | 2020-07-29 | — | — | EP | claimed |
| EP-2940013-B1 | HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND | UBE INDUSTRIES (JP) | 2018-02-21 | — | — | EP | claimed |